Muscle-Specific Expression of Human Insulin Receptor in Transgenic Mice

Variations in skeletal muscle insulin signaling are thought to have important effects on in vivo glucose homeostasis. To address the role of the insulin receptor in insulin action in muscle, we overexpressed human insulin receptors in the skeletal muscle of transgenic mice. A muscle-specific transgene (TMPE/HIR) was constructed by using promotor and enhancer elements derived from the rat MLC1/3 locus coupled to the intact protein-coding region of the human insulin-receptor cDNA. After testing the transgene for expression in cultured C2C12 myotubes, six founder mice transgenic for TMPE/HIR were generated. We determined that one line of mice had significant expression of human insulin-receptor mRNA in skeletal muscle. The analysisof several tissues from these mice by immunoprecipitation of labeled insulin receptors with a human-specific antireceptor antibody, revealed exclusive expression of human insulin receptors in skeletal muscle. Using both human-specific and non-species-specific anti-insulin receptor antibodies, we developed two immunoassays capable of quantitating the relative amounts of human and total insulin receptors in muscle. Compared with nontransgenic littermate controls, the total number ofinsulin receptors was increased by 30% in heterozygous transgenics and 68% in homozygotes. Human insulin-receptor protein contributed substantially to the total insulin-receptor pool present in transgenic muscle (42% for heterozygotes, 61% for homozygotes). Intraperitoneal glucose and insulin tolerance tests were performed with homozygous transgenic and nontransgenic littermate mice. Results with both approaches were significantly different for the two groups of mice, suggesting that the modest increase in insulin receptors in the muscle of transgenic mice causes a direct increase in insulin responsiveness. This study represents the first successful expression of human insulin receptors in transgenic mice. This model and others like it will provide valuable insights into the regulation of insulin-receptor expression and the role of insulin receptors in specific tissues or cell types in metabolism.

[1]  J. Flier,et al.  Alternatively spliced variants of the insulin receptor protein. Expression in normal and diabetic human tissues. , 1992, The Journal of clinical investigation.

[2]  S. O’Rahilly,et al.  Mutant insulin receptors in syndromes of insulin resistance , 1992, Clinical endocrinology.

[3]  G. Merlino Transgenic animals in biomedical research , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  J. Flier,et al.  Insulin resistance--mechanisms, syndromes, and implications. , 1991, The New England journal of medicine.

[5]  J. Tavaré,et al.  Evidence for hybrid rodent and human insulin receptors in transfected cells. , 1991, The Journal of biological chemistry.

[6]  N. Rosenthal,et al.  The myosin light chain enhancer and the skeletal actin promoter share a binding site for factors involved in muscle-specific gene expression , 1991, Molecular and cellular biology.

[7]  J. Flier,et al.  Biologic activities of naturally occurring human insulin receptor mutations. Evidence that metabolic effects of insulin can be mediated by a kinase-deficient insulin receptor mutant. , 1991, The Journal of biological chemistry.

[8]  T. Braun,et al.  A highly conserved enhancer downstream of the human MLC1/3 locus is a target for multiple myogenic determination factors. , 1990, Nucleic acids research.

[9]  J. Flier,et al.  A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. , 1990, The Journal of biological chemistry.

[10]  J. Olefsky The Insulin Receptor: A Multifunctional Protein , 1990, Diabetes.

[11]  D. Accili,et al.  Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients , 1990, Diabetes Care.

[12]  R. Palmiter,et al.  Human sickle hemoglobin in transgenic mice. , 1990, Science.

[13]  J. Kornhauser,et al.  Myosin light chain enhancer activates muscle-specific, developmentally regulated gene expression in transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Flier,et al.  Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. , 1989, Molecular endocrinology.

[15]  N. Rosenthal,et al.  A muscle-specific enhancer is located at the 3' end of the myosin light-chain 1/3 gene locus. , 1988, Genes & development.

[16]  A. Ullrich,et al.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity , 1988, Cell.

[17]  D. James,et al.  Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. , 1985, The American journal of physiology.

[18]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[19]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[20]  K. Struhl,et al.  Current Protocols in Molecular Biology (New York: Greene Publishing Associates and Wiley-Interscience). Host-Range Shuttle System for Gene Insertion into the Chromosomes of Gram-negative Bacteria. , 1988 .

[21]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[22]  C. Kahn The molecular mechanism of insulin action. , 1985, Annual review of medicine.